The 4 analysts offering 12-month price forecasts for Acumen Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 22.00 and a low estimate of 14.00. The median estimate represents a +465.37% increase from the last price of 2.83.
The current consensus among 5 polled investment analysts is to Buy stock in Acumen Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.36
Reporting Date Mar 25
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.